Featured Resource

Clinical Development Brochure

The Clinical Development Brochure provides a detailed overview of the oncology clinical trials, therapeutic targets, and molecules in our pipeline.

Clinical Development Program Brochure
Information on each of the molecules that Lilly has in clinical development can be found here.

BTK Inhibitor

Pirtobrutinib

CDK4/6 Inhibitor

Abemaciclib

FGFR3 Inhibitor

LOXO-435

FRα Antibody-Drug Conjugate

LY4170156

KRAS G12C Inhibitor

Olomorasib

Nectin-4 Antibody-Drug Conjugate

ETx-22, LY4101174

PI3Kα Inhibitor

LOXO-783

RET Inhibitor

Selpercatinib

Selective ER Degrader

Imlunestrant

VEGF Receptor-2 Antagonist

Ramucirumab

For information on trial enrollment, locations, and more, call 1-800-545-5979.